Archives

  • 2026-10
  • 2026-09
  • 2026-08
  • 2026-07
  • 2026-06
  • 2026-05
  • 2025-12
  • 2025-11
  • 2025-10
  • Polyphenol Nanoparticles for mRNA Delivery

    2026-09-21

    Non-viral mRNA delivery depends on more than particle association with cells: a formulation must protect mRNA, support internalization, promote endosomal escape, release cargo in a usable form, and preserve translation. Lu et al. examined these linked steps using polyphenol-mediated nanoparticles and placed the resulting mRNA system alongside an SM-102 lipid nanoparticle (LNP) comparator. The study therefore provides a useful formulation contrast for research on ALC-0315 and related ionizable-lipid systems, while offering no direct evidence about ALC-0315 itself.

    Research Question

    The study asked whether nucleic acids could be assembled under mild conditions into biofunctional nanoparticles by first complexing them with a polyphenol and then capping the complexes with a cationic polypeptide. For mRNA delivery, the principal formulation used tannic acid (TA), firefly-luciferase mRNA (mRNAFLuc), and polyarginine (PArg), producing what the authors termed mRNA-PPNPs.

    The central delivery question was not simply whether fluorescent material entered cells, but whether the incorporated mRNA retained functional activity. The paper therefore examined encapsulation, pH-dependent release, cell association, endosomal localization, membrane leakage, and reporter expression. A separate SM-102 LNP was used as a functional comparator. Its lipid composition was SM-102, DSPC, cholesterol, and DMG-PEG2000 at a molar ratio of 50:10:38.5:1.5. The study did not independently vary the ionizable-lipid or PEG-lipid components, and it did not evaluate ALC-0315.

    Study Design and Methods

    For mRNA-PPNP assembly, 1 μg of nucleic acid was mixed with TA and incubated before addition of PArg, PLys, or PHis. The selected TA-to-mRNAFLuc mass ratio was 0.5:1 because it produced the narrowest reported size distribution, with a polydispersity index of 0.14. Transmission electron microscopy and dynamic light scattering were used for particle characterization, while RiboGreen fluorescence of unencapsulated RNA in the supernatant was used to calculate encapsulation efficiency.

    The study evaluated colloidal stability in buffers, cell-culture medium, serum-containing medium, and mouse plasma. Release was measured after incubation at pH 4, 5.5, 6.5, and 7, as well as in serum-containing medium. Urea, Tween 20, and sodium chloride were used as chemical challenges to examine the contributions of hydrogen-bonding, hydrophobic, and electrostatic interactions to particle integrity.

    Cell association was assessed with AF647- or rhodamine-labeled mRNA-PPNPs by flow cytometry and confocal microscopy. These fluorescent signals report association or localization of labeled nanoparticle-associated material; they are not measurements of translated protein. Endosomal involvement was examined by colocalization with LysoTracker-labeled compartments, and calcein leakage was used as a cellular membrane-destabilization readout.

    Functional mRNA delivery was tested in HEK293T cells using mRNAFLuc and mRNA encoding mCherry. Luciferase luminescence and mCherry fluorescence were used as reporter-expression outputs after delivery. The study also included siRNA and plasmid-DNA experiments, but those were supporting demonstrations of platform versatility rather than mRNA experiments: GFP siRNA was used for gene silencing, whereas FLuc plasmid DNA was evaluated after a separate 48-hour treatment.

    Main Findings

    Particle formation, encapsulation, and release

    The TA/mRNA/PArg formulation formed particles with a reported size of 32.0 ± 9.7 nm and mRNA encapsulation efficiency exceeding 90% for the selected formulation. Interaction studies supported binding between TA and mRNA and between TA and PArg. The authors concluded that hydrophobic and electrostatic interactions were the main stabilizing forces: Tween 20 caused particle disassembly and approximately 50% mRNA release, whereas sodium chloride caused a size increase and approximately 15% release.

    Release was pH responsive. Approximately 74% of the incorporated mRNA was released within 24 hours at pH 4, compared with 11% at pH 7. About 64% was released within 24 hours in DMEM containing 10% fetal bovine serum. These results indicate that the formulation was comparatively less releasing under near-neutral conditions and more releasing under acidic conditions. They do not, by themselves, establish that release occurred specifically inside endosomes.

    Cell association was not equivalent to functional expression

    AF647-labeled PArg- and PLys-based mRNA-PPNPs showed at least 80% association with HEK293T cells, while PHis-based particles showed approximately 50% association under the reported conditions. For the representative PArg formulation, association was negligible after 1 hour, increased at 4 and 6 hours, and exceeded 90% after 24 hours. Confocal images placed most of the associated fluorescence in the cytoplasm.

    These uptake measurements should be interpreted separately from translation. The labeled-RNA or particle signal demonstrates cellular association and intracellular localization of fluorescent material, but it does not prove that intact mRNA reached the cytosol or was translated. Functional evidence came from reporter assays: PArg-based mRNA-PPNPs produced luciferase expression 52-fold higher than mRNA-PArg complexes, and TA/PArg particles carrying mRNA encoding mCherry produced greater mCherry expression than untreated cells or cells treated with mRNA-PArg complexes.

    Endosomal escape was supported indirectly

    Compared with mRNA-PArg complexes, mRNA-PPNPs showed less overlap with LysoTracker-labeled endo/lysosomal compartments. For the PArg example, the reported Pearson correlation coefficient was 0.537 for mRNA-PPNPs versus 0.675 for mRNA-PArg complexes. In a calcein leakage experiment, cells treated with PArg-based mRNA-PPNPs displayed diffuse rather than punctate calcein fluorescence, which the authors interpreted as evidence of endosomal or lysosomal membrane destabilization.

    These findings are consistent with an endosomal-escape contribution to the higher reporter expression, but the experiments do not directly quantify the fraction of mRNA escaping into the cytosol. The paper appropriately presents the proposed sequence—acidification and enzymatic conditions promoting disassembly, followed by local component accumulation and membrane destabilization—as an interpretation rather than a directly measured intracellular mechanism.

    Comparison with the SM-102 LNP

    The SM-102 LNP comparator produced higher mRNA transfection than the mRNA-PPNP formulation in the reported luciferase experiment. The authors attributed the lower PPNP output partly to its relatively slow mRNA-release profile. This comparison is important for delivery research because it separates high cell association from the overall efficiency of productive mRNA delivery: the PPNPs associated strongly with cells, yet the SM-102 LNP generated greater reporter output.

    The comparison should not be read as a head-to-head evaluation of ALC-0315 versus SM-102. ALC-0315 was not used, and the study did not dissect the independent contributions of the ionizable lipid, phospholipid, cholesterol, or DMG-PEG2000 in the LNP comparator.

    Delivery-related tolerability in vitro

    TA/mRNA/PArg particles showed negligible cytotoxicity in HEK293T cells after 24 hours at the tested PArg concentration. Hemolysis was minimal at the tested pH values, and RAW264.7 macrophages showed no significant increase in TNF-α or IL-6 secretion compared with untreated cells under the reported conditions. These results support favorable short-term in vitro tolerability for the tested formulations, but they do not establish systemic tolerability, pharmacokinetics, immunogenicity in vivo, or clinical safety.

    Limitations

    • The work did not test ALC-0315 and was not designed to determine how ALC-0315 compares with SM-102 or with the polyphenol system.
    • The LNP comparison used a complete SM-102/DSPC/cholesterol/DMG-PEG2000 formulation, so the study does not identify which individual lipid component accounted for its functional performance.
    • Cell association was measured with fluorescently labeled material. Those signals should not be equated with intact cytosolic mRNA or translated protein output.
    • Endosomal escape was inferred from LysoTracker colocalization and calcein leakage rather than measured directly as cytosolic delivery of functional mRNA.
    • The study reported in vitro stability and release behavior, but it did not provide in vivo biodistribution, organ targeting, tissue-level expression, or pharmacokinetic evidence.
    • Reporter mRNAs were used to evaluate delivery function. The study therefore demonstrates formulation performance with FLuc and mCherry reporters, not therapeutic efficacy or disease modification.
    • The siRNA and plasmid-DNA experiments demonstrate broader nucleic-acid compatibility, but their results cannot be transferred directly to mRNA delivery because the cargos, readouts, and treatment times differ.

    Source

    Lu, M., Chen, J., Lin, Z., et al. “Polyphenol-Mediated Nucleic Acid Complexation Generates Biofunctional Nanoparticles.” Chemistry of Materials. https://doi.org/10.1021/acs.chemmater.6c01292.